Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 + Chemotherapy vs Chemotherapy in Advanced NSCLC
NCT07330596Phase 2Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Oct 2025
- Primary completion
- Jan 2028
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in non-small cell lung cancer (NSCLC), sponsored by Anhui Provincial Tumor Hospital. Started Oct 2025; status: recruiting.
02
Drugs
QL1706
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07330596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07330596.